Kursprognose für Ernexa Therapeutics Inc (ERNA)ERNAErnexa Therapeutics Inc

Alphio's ERNA stock price prediction model matches the current Ernexa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.90 (+0.93%). The 1-week path is $1.98 (+5.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Eterna Therapeutics Inc (ERNA) is not a good buy right now due to its poor financial performance and negative market trends. The stock has a current price of 1.88, which is a drastic drop of 93.52% year-to-date. Additionally, the RSI is at 36.6, indicating that the stock is nearing oversold territory, but this alone does not justify a buy given the lack of revenue and significant losses reported. The company has a forward P/E of 0, indicating no expected earnings growth, and a gross margin of 0% for the upcoming quarters, which raises concerns about its operational viability. The main risk is the ongoing net losses, with the most recent quarter showing a loss of 5.51 million, which could further erode investor confidence.

Ernexa Therapeutics Inc (ERNA) last closed at $1.88, gaining +2.73%. These facts feed the 1-day and 1-week ERNA price prediction above.